Synthon International Holding Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Private

  • Employees
  • 1,600

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 4

  • Investments
  • 5

Synthon International Holding General Information

Description

Operator of a pharmaceutical company intended to specialize in developing and manufacturing quality generic medicines for patients around the world. The company specializes in developing and manufacturing generic and hybrid medicines, enabling medical professionals to help improve the health and well-being of their patients.

Contact Information

Website
www.synthon.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Microweg 4, Building L
  • 6545 CM Nijmegen
  • Netherlands
+31 024
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • Microweg 4, Building L
  • 6545 CM Nijmegen
  • Netherlands
+31 024

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synthon International Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Synthon International Holding‘s full profile, request access.

Request a free trial

Synthon International Holding Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to specialize in developing and manufacturing quality generic medicines fo
Pharmaceuticals
Nijmegen, Netherlands
1,600 As of 2025

Sao Paulo, Brazil

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Synthon International Holding Competitors (38)

One of Synthon International Holding’s 38 competitors is Glenmark Farmacêutica, a Corporation company based in Sao Paulo, Brazil.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Glenmark Farmacêutica Corporation Sao Paulo, Brazil
Evonile Pharma Private Equity-Backed Mumbai, India
Pil-psychotropics India Corporation Faridabad, India
Lannett Corporate Backed or Acquired Trevose, PA
Beloteca Corporation San Diego, CA
You’re viewing 5 of 38 competitors. Get the full list »

Synthon International Holding Patents

Synthon International Holding Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260138954-A1 Amorphous solid form and pharmaceutical compositions of lenvatinib besylate Pending 18-Aug-2025
WO-2026027799-A2 Amorphous solid form and pharmaceutical compositions of lenvatinib besylate Pending 18-Aug-2025
WO-2026027799-A3 Amorphous solid form and pharmaceutical compositions of lenvatinib besylate Pending 18-Aug-2025
WO-2026234202-A1 Process for preparation of asciminib Pending 09-May-2025
WO-2026202057-A1 Particles of l-arginine salt of etrasimod Pending 24-Mar-2025 C07D209/94
To view Synthon International Holding’s complete patent history, request access »

Synthon International Holding Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synthon International Holding Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Synthon International Holding‘s full profile, request access.

Request a free trial

Synthon International Holding Investments & Acquisitions (5)

Synthon International Holding’s most recent deal was a Buyout/LBO with Synthon International Holding (6,000 Meter Square Facility in Spain). The deal was made on 29-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Synthon International Holding (6,000 Meter Square Facility in Spain) 29-Jun-2026 Buyout/LBO Buildings and Property
Biolex Therapeutics (Lex System Operations) 20-Apr-2012 Merger/Acquisition Drug Discovery
Syntarga 23-Jun-2011 Merger/Acquisition Drug Discovery
Naf Laboratorio 08-Mar-2010 Merger/Acquisition Drug Discovery
Synthon Chile 11-Jun-2007 Merger/Acquisition Pharmaceuticals
To view Synthon International Holding’s complete investments and acquisitions history, request access »

Synthon International Holding Exits (1)

Synthon International Holding’s most recent exit was on 08-Mar-2010 from Naf Laboratorio. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Naf Laboratorio 08-Mar-2010 Completed
To view Synthon International Holding’s complete exits history, request access »

Synthon International Holding Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Syntarga Nijmegen, Netherlands 2002

Synthon International Holding FAQs

  • When was Synthon International Holding founded?

    Synthon International Holding was founded in 1991.

  • Where is Synthon International Holding headquartered?

    Synthon International Holding is headquartered in Nijmegen, Netherlands.

  • What is the size of Synthon International Holding?

    Synthon International Holding has 1,600 total employees.

  • What industry is Synthon International Holding in?

    Synthon International Holding’s primary industry is Pharmaceuticals.

  • Is Synthon International Holding a private or public company?

    Synthon International Holding is a Private company.

  • What is the current valuation of Synthon International Holding?

    The current valuation of Synthon International Holding is .

  • What is Synthon International Holding’s current revenue?

    The current revenue for Synthon International Holding is .

  • How much funding has Synthon International Holding raised over time?

    Synthon International Holding has raised $499M.

  • Who are Synthon International Holding’s investors?

    Goldman Sachs Asset Management has invested in Synthon International Holding.

  • Who are Synthon International Holding’s competitors?

    Glenmark Farmacêutica, Evonile Pharma, Pil-psychotropics India, Lannett, and Beloteca are some of the 38 competitors of Synthon International Holding.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process